{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:24:58Z","timestamp":1775597098009,"version":"3.50.1"},"reference-count":131,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ymgme.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T18:45:50Z","timestamp":1494269150000},"page":"57-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: A review of the literature"],"prefix":"10.1016","volume":"121","author":[{"given":"Darren","family":"Janzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0276-0276","authenticated-orcid":false,"given":"Elsa G.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2017.05.005_bb0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-l-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajmg.1320460222","article-title":"Long-term outcome of Hurler syndrome following bone marrow transplantation","volume":"46","author":"Whitley","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0030","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","article-title":"Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome","volume":"87","author":"Peters","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0035","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"Hurler syndrome: II outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0040","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa032613","article-title":"Cord-blood transplants from unrelated donors in patients with Hurler's syndrome","volume":"350","author":"Staba","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0045","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1651-2227.2008.00811.x","article-title":"Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT)","volume":"8","author":"Malm","year":"2008","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0050","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1399-3046.2011.01595.x","article-title":"Variable disease progression after successful stem cell transplantation: prospective follow-up investigations in eight patients with Hurler syndrome","volume":"15","author":"Grigull","year":"2011","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ana.24246","article-title":"Early treatment is associated with improved cognition in Hurler syndrome","volume":"76","author":"Poe","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0060","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"Aldenhoven","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/8904_2015_521","article-title":"Long-term cognitive and functional outcomes in children with mucopolysaccharidosis (MPS)-IH (Hurler syndrome) treated with hematopoietic cell transplantation","volume":"29","author":"Kunin-Batson","year":"2016","journal-title":"JIMD"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2015.06.002","article-title":"Neurocognition across the spectrum of mucopolysaccharidosis type I: age, severity, and treatment","volume":"116","author":"Shapiro","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ymgme.2016.04.006","article-title":"Neurocognitive clinical outcome assessments for diseases of inborn errors of metabolism and other rare conditions","volume":"118","author":"Shapiro","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.outlook.2014.11.006","article-title":"Implementing common data elements across studies to advance research","volume":"63","author":"Cohen","year":"2015","journal-title":"Nurs. Outlook"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0085","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","article-title":"The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes","volume":"63","author":"Mokkink","year":"2010","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0090","series-title":"Standards for Educational and Psychological Testing","isbn-type":"print","author":"American Educational Research Association, American Psychological Association, National Council on Measurement in Education","year":"2014","ISBN":"https:\/\/id.crossref.org\/isbn\/9780935302356"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/8904_2013_269","article-title":"Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndrome","volume":"13","author":"Delaney","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0100","series-title":"The Rising Curve: Long-term Gains in IQ and Related Measures","first-page":"25","article-title":"IQ gains over time: Toward finding the causes","author":"Flynn","year":"1998"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09297049.2016.1216536","article-title":"Selecting measures for the neurodevelopmental assessment of children in low-and middle-income countries","author":"Semrud-Clikeman","year":"2016","journal-title":"Child Neuropsychol."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0110","series-title":"Bayley Scales of Infant and Toddler Development","author":"Bayley","year":"2006"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0115","series-title":"Mullen Scales of Early Learning Manual","author":"Mullen","year":"1995"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0120","series-title":"Differential Ability Scales","author":"Elliott","year":"2007"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0125","series-title":"Kaufman Assessment Battery for Children","author":"Kaufman","year":"2004"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0130","series-title":"Leiter International Performance Scale","author":"Roid","year":"2013"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0135","series-title":"Stanford-Binet Intelligence Scales","author":"Roid","year":"2003"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0140","series-title":"Wechsler Preschool and Primary Scale of Intelligence","author":"Wechsler","year":"2012"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0145","series-title":"Wechsler Intelligence Scale for Children","author":"Wechsler","year":"2014"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0150","series-title":"Wechsler Adult Intelligence Scale","author":"Wechsler","year":"2008"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0155","series-title":"Wechsler Abbreviated Scale of Intelligence","author":"Wechsler","year":"2011"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0160","series-title":"Vineland Adaptive Behavior Scales","author":"Sparrow","year":"2016"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0165","series-title":"Scales of Independent Behavior-Revised","author":"Bruininks","year":"1996"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0170","series-title":"Adaptive Behavior Assessment System, Manual, and Intervention Planner","author":"Harrison","year":"2015"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0175","series-title":"Griffiths Scales of Child Development","article-title":"Association for Research in Infant and Child Development","year":"2017"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1651-2227.2008.00651.x","article-title":"Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective","volume":"97","author":"Martin","year":"2008","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0185","series-title":"Lysosomal Storage Diseases: Early Diagnosis and New Treatments","first-page":"81","article-title":"Psychological assessment and support for patients with mucopolysaccharidosis","year":"2010"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0190","series-title":"Advances in Child Neuropsychology","first-page":"119","article-title":"Dementia in childhood: Issues in neuropsychological assessment with application to the natural history and treatment of degenerative storage diseases","volume":"Volume III","author":"Shapiro","year":"1993"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0195","series-title":"Principles and Practice of Lifespan Developmental Neuropsychology","first-page":"427","article-title":"Metabolic and neurodegenerative disorders across the lifespan","author":"Ziegler","year":"2010"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0200","series-title":"Handbook of Research in Pediatric and Clinical Child Psychology: Practical Strategies and Methods","first-page":"281","article-title":"Multi-institutional and multidisciplinary research collaboration: strategies and lessons from cooperative trials","year":"2000"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0205","first-page":"297","article-title":"Interrater reliability of the Bayley III test in the Italian Northern-Adriatic Cohort II","volume":"37","author":"Deroma","year":"2013","journal-title":"Epidemiol. Prev."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00787-004-0383-1","article-title":"A prospective longitudinal study of early cognitive development in tuberous sclerosis","volume":"13","author":"Humphrey","year":"2004","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0215","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1469-7610.2006.01531.x","article-title":"Development in infants with autism spectrum disorders: a prospective study","volume":"47","author":"Landa","year":"2006","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1352\/1944-7558-116.5.331","article-title":"Convergent validity of the Mullen Scales of Early Learning and the differential ability scales in children with autism spectrum disorders","volume":"116","author":"Bishop","year":"2011","journal-title":"Am. J. Intellect. Dev. Disabil."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0225","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1037\/pas0000116","article-title":"Convergent and divergent validity of the Mullen Scales of Early Learning in young children with and without autism spectrum disorder","volume":"27","author":"Swineford","year":"2015","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0230","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/DBP.0000000000000110","article-title":"Predictive validity of the Bayley, at 2 years for intelligence quotient at 4 years in preterm infants","volume":"35","author":"Bode","year":"2014","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0235","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/jir.12291","article-title":"Assessment of cognition and language in the early diagnosis of autism spectrum disorder: usefulness of the Bayley Scales of infant and toddler development","volume":"60","author":"TorrasMa\u00f1\u00e1","year":"2016","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0240","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/0734282913517526","article-title":"Cognitive tests in early childhood psychometric and cultural considerations","volume":"32","author":"Williams","year":"2014","journal-title":"J. Psychoeduc. Assess."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09297049.2016.1216536","article-title":"Selecting measures for the neurodevelopmental assessment of children in low-and middle-income countries","volume":"10","author":"Semrud-Clikeman","year":"2016","journal-title":"Child Neuropsychol."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","volume":"12","author":"Krivit","year":"1999","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0255","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpeds.2015.11.079","article-title":"A prospective natural history study of mucopolysaccharidosis type IIIA","volume":"170","author":"Shapiro","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0260","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1542\/peds.2010-1274","article-title":"Natural progression of neurological disease in mucopolysaccharidosis type II","volume":"127","author":"Holt","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0265","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10545-013-9661-8","article-title":"Natural history of Sanfilippo syndrome type a","volume":"37","author":"Buhrman","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-l-iduronidase (laronidase)","volume":"120","author":"Wraith","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2017.05.005_bb0275","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/BF00711520","article-title":"Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype","volume":"16","author":"Hopwood","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0280","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/adc.76.2.92","article-title":"Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres","volume":"76","author":"Vellodi","year":"1997","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0285","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00220080","article-title":"Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II)","volume":"90","author":"Crotty","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0290","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1172-6-43","article-title":"Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)","volume":"6","author":"Valstar","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0295","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpeds.2011.03.019","article-title":"Early clinical markers of central nervous system involvement in mucopolysaccharidosis type II","volume":"159","author":"Holt","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0300","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0387-7604(01)00242-X","article-title":"Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B)","volume":"23","author":"Zafeiriou","year":"2001","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.6000\/2292-2598.2016.04.01.8","article-title":"Mucopolysaccharidosis II, IV-A and VI: first Colombian neuropsychological characterization","volume":"4","author":"Ib\u00e1\u00f1ez","year":"2016","journal-title":"Intellect. Disabl. Diagn. J."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0310","first-page":"273","article-title":"Prospective study of 11 Brazilian patients with mucopolysaccharidosis II","volume":"82","author":"Pinto","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0315","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2016.08.002","article-title":"A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: implications for clinical trial design","volume":"119","author":"Truxal","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0320","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ymgmr.2015.03.011","article-title":"Enzymatic replacement therapy for Hunter disease: up to 9years experience with 17 patients","volume":"3","author":"Parini","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0325","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.bmt.1703395","article-title":"Outcome of second hematopoietic cell transplantation in Hurler syndrome","volume":"29","author":"Grewal","year":"2002","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.ymgme.2017.05.005_bb0330","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-3476(96)70202-0","article-title":"Bone marrow transplantation in Hunter syndrome","volume":"129","author":"McKinnis","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0335","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/8904_2013_289","article-title":"Enzyme replacement therapy in mucopolysaccharidosis II patients under 1year of age","volume":"14","author":"Lampe","year":"2014","journal-title":"JIMD Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2017.05.005_bb0340","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ymgme.2016.05.006","article-title":"A phase 1\/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA","volume":"118","author":"Jones","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/8904_2014_350","article-title":"Early umbilical cord blood-derived stem cell transplantation does not prevent neurological deterioration in mucopolysaccharidosis type III","volume":"18","author":"Welling","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0350","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jpeds.2012.07.052","article-title":"Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome","volume":"162","author":"Eisengart","year":"2013","journal-title":"J. Pediatr."},{"issue":"7\u20138","key":"10.1016\/j.ymgme.2017.05.005_bb0355","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1440-1754.2009.01537.x","article-title":"Combined enzyme replacement and haematopoietic stem cell transplantation in Hurler syndrome","volume":"45","author":"Bijarnia","year":"2009","journal-title":"J. Paediatr. Child Health"},{"issue":"6","key":"10.1016\/j.ymgme.2017.05.005_bb0360","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/BF00711520","article-title":"Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype","volume":"16","author":"Hopwood","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0365","first-page":"403","article-title":"284 long-term outcome after hematopoietic stem cell transplantation (HCT) in patients affected by Mucopolysaccharidosis I Hurler (MPS IH)","volume":"58","author":"Sersale","year":"2005","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.ymgme.2017.05.005_bb0370","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2017.05.005_bb0375","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1399-3046.2007.00720.x","article-title":"Pre-stem cell transplantation enzyme replacement therapy in Hurler syndrome does not lead to significant antibody formation or delayed recovery of the endogenous enzyme post-transplant: a case report","volume":"11","author":"Soni","year":"2007","journal-title":"Pediatr. Transplant."},{"issue":"10","key":"10.1016\/j.ymgme.2017.05.005_bb0380","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.bmt.1702397","article-title":"Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia","volume":"25","author":"Mullen","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0385","series-title":"Mental Measurements Yearbook","article-title":"Review of the Stanford-Binet Intelligence Scales","volume":"16","author":"Kush","year":"2004"},{"issue":"4","key":"10.1016\/j.ymgme.2017.05.005_bb0390","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0734282913511051","article-title":"Concurrent validity of the WISC-IV and DAS-II in children with autism spectrum disorder","volume":"32","author":"Kuriakose","year":"2014","journal-title":"J. Psychoeduc. Assess."},{"issue":"5","key":"10.1016\/j.ymgme.2017.05.005_bb0395","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1080\/09297049.2015.1020775","article-title":"Concurrent validity of the differential ability scales, with the Mullen Scales of Early Learning in young children with and without neurodevelopmental disorders","volume":"22","author":"Farmer","year":"2016","journal-title":"Child Neuropsychol."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0400","series-title":"A Comparison Study: Kaufman Assessment Battery for Children, Second Edition (KABC-II) and Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV) with Referred Students","first-page":"423","author":"McKown","year":"2010"},{"issue":"3","key":"10.1016\/j.ymgme.2017.05.005_bb0405","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/mrdd.20076","article-title":"General measures of cognition for the preschool child","volume":"11","author":"Lichtenberger","year":"2005","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"issue":"7","key":"10.1016\/j.ymgme.2017.05.005_bb0410","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3174\/ajnr.A2032","article-title":"Correlation of automated volumetric analysis of brain MR imaging with cognitive impairment in a natural history study of mucopolysaccharidosis II","volume":"31","author":"Fan","year":"2010","journal-title":"Am. J. Neuroradiol."},{"issue":"5","key":"10.1016\/j.ymgme.2017.05.005_bb0415","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jpeds.2014.01.007","article-title":"Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA","volume":"164","author":"Rumsey","year":"2014","journal-title":"J. Pediatr."},{"issue":"9","key":"10.1016\/j.ymgme.2017.05.005_bb0420","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/hmg\/1.9.755","article-title":"Mutation R468W of the iduronate-2-sulfatase gene in mild Hunter syndrome (mucopolysaccharidosis type II) confirmed by in vitro mutagenesis and expression","volume":"1","author":"Crotty","year":"1992","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.ymgme.2017.05.005_bb0425","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/adc.57.11.828","article-title":"Mild form of Hunter's syndrome: clinical delineation based on 31 cases","volume":"57","author":"Young","year":"1982","journal-title":"Arch. Dis. Child."},{"issue":"10","key":"10.1016\/j.ymgme.2017.05.005_bb0430","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1469-8749.2012.04228.x","article-title":"Non-convulsive status epilepticus of frontal origin in mucopolysaccharidosis type II successfully treated with ethosuximide","volume":"54","author":"Bonanni","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0435","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-2007-973503","article-title":"Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome)","volume":"5","author":"Barone","year":"1999","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.ymgme.2017.05.005_bb0440","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajmg.a.20515","article-title":"Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses","volume":"125","author":"Gabrielli","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"issue":"4","key":"10.1016\/j.ymgme.2017.05.005_bb0445","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2015.10.004","article-title":"Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I","volume":"116","author":"Moreau","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2017.05.005_bb0450","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymgme.2009.12.019","article-title":"Cognitive and neuroradiological improvement in three patients with attenuated MPS I treated by laronidase","volume":"100","author":"Valayannopoulos","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2017.05.005_bb0455","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2230.1999.00448.x","article-title":"Skin eruption as the presenting sign of Hunter syndrome IIB","volume":"24","author":"Demitsu","year":"1999","journal-title":"Clin. Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.ymgme.2017.05.005_bb0460","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2014.12.299","article-title":"Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II","volume":"114","author":"Yund","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2017.05.005_bb0465","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/gim.2015.36","article-title":"A phase I\/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II","volume":"18","author":"Muenzer","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0470","first-page":"S176","article-title":"Poor cognitive outcome of eleven children with Sanfilippo syndrome after bone marrow transplantation and successful engraftment","volume":"15","author":"Klein","year":"1995","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.ymgme.2017.05.005_bb0475","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/13816818309007145","article-title":"Ocular ultrastructural studies of two cases of the Hurler syndrome (systemic mucopolysaccharidosis IH)","volume":"2","author":"Chao Chan","year":"1983","journal-title":"Ophthalmic Paediatr. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2017.05.005_bb0480","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2147\/nedt.2006.2.3.381","article-title":"Longitudinal neurocognitive outcome in an adolescent with Hurler-Scheie syndrome","volume":"2","author":"Elkin","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.ymgme.2017.05.005_bb0485","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7603\/s40681-014-0007-0","article-title":"Case report of Chromosome 3q25 deletion syndrome or Mucopolysaccharidosis IIIB","volume":"4","author":"Chang","year":"2014","journal-title":"BioMedicine (Taipei)"},{"issue":"3","key":"10.1016\/j.ymgme.2017.05.005_bb0490","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0829573513493982","article-title":"Test review: Wechsler abbreviated scale of intelligence second edition","volume":"28","author":"Irby","year":"2013","journal-title":"Can. J. Sch. Psychol."},{"issue":"7","key":"10.1016\/j.ymgme.2017.05.005_bb0495","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nrleng.2011.10.005","article-title":"Neuroimaging findings in patient series with mucopolysaccharidosis","volume":"27","author":"Gero","year":"2012","journal-title":"Neurolog\u00eda (English Edition)."},{"issue":"5","key":"10.1016\/j.ymgme.2017.05.005_bb0500","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF02396619","article-title":"Radiological findings in patients with mucopolysaccharidosis IH\/S (Hurler-Scheie syndrome)","volume":"17","author":"Schmidt","year":"1987","journal-title":"Pediatr. Radiol."},{"issue":"1","key":"10.1016\/j.ymgme.2017.05.005_bb0505","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1442-200X.2008.02652.x","article-title":"Psychological status of patients with mucopolysaccharidosis type II and their parents","volume":"51","author":"Kuratsubo","year":"2009","journal-title":"Pediatr. Int."},{"issue":"6","key":"10.1016\/j.ymgme.2017.05.005_bb0510","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3174\/ajnr.A0510","article-title":"Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II","volume":"28","author":"Vedolin","year":"2007","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"3","key":"10.1016\/j.ymgme.2017.05.005_bb0515","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000113511","article-title":"Otologic manifestations of Hunter syndrome and their relationship with speech development","volume":"13","author":"Cho","year":"2008","journal-title":"Audiol. Neurootol."},{"issue":"6","key":"10.1016\/j.ymgme.2017.05.005_bb0520","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.22092","article-title":"Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations","volume":"68","author":"Valstar","year":"2010","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2017.05.005_bb0525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01804384","article-title":"Sanfilippo B disease: a re-examination of a particular sibship after 12 years","volume":"14","author":"Di Natale","year":"1991","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2017.05.005_bb0530","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2012.07.016","article-title":"An exploratory study of brain function and structure in mucopolysaccharidosis type I: Long term observations following hematopoietic cell transplantation (HCT)","volume":"107","author":"Shapiro","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0535","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgmr.2016.03.006","article-title":"Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI","volume":"7","author":"Ahmed","year":"2016","journal-title":"Mol Genet. Metab. Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2017.05.005_bb0540","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2013.11.014","article-title":"Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the \u03b1-l-iduronidase gene in Hurler\u2013Scheie syndrome","volume":"111","author":"Ahmed","year":"2014","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0545","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ymgmr.2016.03.005","article-title":"A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II","volume":"7","author":"Shapiro","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"12","key":"10.1016\/j.ymgme.2017.05.005_bb0550","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","article-title":"Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources","volume":"31","author":"Souillet","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"10.1016\/j.ymgme.2017.05.005_bb0555","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.bbmt.2016.08.015","article-title":"Allogeneic hematopoietic stem cell transplantation in thirty-four pediatric cases of mucopolysaccharidosis\u2014a ten-year report from the China children transplant group","volume":"22","author":"Wang","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.ymgme.2017.05.005_bb0560","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pediatrneurol.2012.08.010","article-title":"Enzyme replacement therapy in an attenuated case of mucopolysaccharidosis type I (Scheie syndrome): a 6.5-year detailed follow-up","volume":"47","author":"Jurecka","year":"2012","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0565","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgmr.2015.04.003","article-title":"Enzyme replacement therapy in Hurler syndrome after failure of hematopoietic transplant","volume":"3","author":"Arranz","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2017.05.005_bb0570","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00310920","article-title":"Bone marrow transplant in a case of mucopolysaccharidosis I Scheie phenotype: skin ultrastructure before and after transplantation","volume":"82","author":"Navarro","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.ymgme.2017.05.005_bb0575","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmg.2010.07.013","article-title":"First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS)","volume":"53","author":"Alcalde-Martin","year":"2010","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0580","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007644","article-title":"Unexpected outcome (positive or negative) including adverse drug reactions: Hunter syndrome follow-up after 1 year of enzyme-replacement therapy","author":"Puiu","year":"2013","journal-title":"BMJ Case Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2017.05.005_bb0585","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00004703-200608000-00002","article-title":"Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation","volume":"27","author":"Bjoraker","year":"2006","journal-title":"J. Dev. Behav. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2017.05.005_bb0590","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10545-014-9737-0","article-title":"Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey","volume":"38","author":"Brands","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2017.05.005_bb0595","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/PRM-140285","article-title":"Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI","volume":"7","author":"Stevenson","year":"2014","journal-title":"J. Pediatr. Rehabil. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2017.05.005_bb0600","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10897-013-9665-4","article-title":"MPS II: adaptive behavior of patients and impact on the family system","volume":"23","author":"Needham","year":"2014","journal-title":"J. Genet. Couns."},{"issue":"1","key":"10.1016\/j.ymgme.2017.05.005_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1866-1955-6-46","article-title":"An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III","volume":"6","author":"Cross","year":"2014","journal-title":"J. Neurodev. Disord."},{"issue":"3","key":"10.1016\/j.ymgme.2017.05.005_bb0610","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MPH.0b013e3182050945","article-title":"Long-term adaptive functioning outcomes of children with inherited metabolic and genetic diseases treated with hematopoietic stem cell transplantation in a single large pediatric center: parents' perspective","volume":"33","author":"Gassas","year":"2011","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.ymgme.2017.05.005_bb0615","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2522\/ptj.20070017","article-title":"Gross motor development of children with Hurler syndrome after umbilical cord blood transplantation","volume":"87","author":"Dusing","year":"2007","journal-title":"Phys. Ther."},{"issue":"6","key":"10.1016\/j.ymgme.2017.05.005_bb0620","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1089\/hum.2013.238","article-title":"Intracerebral administration of adeno-associated viral vector serotype rh.10 carrying human SGSH and SUMF1 cDNAs in children with mucopolysaccharidosis type IIIA disease: results of a phase I\/II trial","volume":"25","author":"Tardieu","year":"2014","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.ymgme.2017.05.005_bb0625","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jpeds.2011.04.040","article-title":"Evaluation of miglustat treatment in patients with type III mucopolysaccharidosis: a randomized, double-blind, placebo-controlled study","volume":"159","author":"Guffon","year":"2011","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2017.05.005_bb0630","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12519-009-0062-x","article-title":"Progression of organ manifestations upon enzyme replacement therapy in a patient with mucopolysaccharidosis type I\/Hurler","volume":"5","author":"Mercimek-Mahmutoglu","year":"2009","journal-title":"World J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2017.05.005_bb0635","first-page":"253","article-title":"Long-term enzyme replacement therapy in a severe case of mucopolysaccharidosis type II (Hunter syndrome)","volume":"15","author":"Papadia","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0640","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/8904_2014_317","article-title":"A Hunter patient with a severe phenotype reveals two large deletions and two duplications extending 1.2Mb distally to IDS locus","volume":"17","author":"Zanetti","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2017.05.005_bb0645","series-title":"SON-R 6\u201340: Snijders-Oomen Nonverbal Intelligence Test","author":"Tellegen","year":"2011"},{"issue":"1","key":"10.1016\/j.ymgme.2017.05.005_bb0650","doi-asserted-by":"crossref","first-page":"17","DOI":"10.6033\/specialeducation.2.17","article-title":"Comparison of Kyoto scale of psychological development and Bayley scales of infant development second edition among Japanese infants","volume":"2","author":"Tatsuta","year":"2013","journal-title":"J. Spec. Educ. Res."},{"issue":"3","key":"10.1016\/j.ymgme.2017.05.005_bb0655","first-page":"55","article-title":"A comparison of three adaptive behavior measures in relation to cognitive level and severity of autism","volume":"15","author":"Wells","year":"2009","journal-title":"J. Dev. Disabil."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217302093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217302093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T04:00:42Z","timestamp":1602043242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719217302093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1096719217302093"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.05.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: A review of the literature","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}